Supplement Aims and Scope
Articles should focus on stem cell biology and may include the following topics:
Stem cell properties § § Types, including hematopoietic stem cells, embryonic stem cells, mesenchymal stem cells and induced pluripotent stem cells, plasticity and immunophenotype. Stem cell biology § § Microenvironment niches, including bone marrow and fetal liver, gene regulation including that of transcription factors, non-coding RNAs and epigenetics and cell development. Therapeutic approaches § § Sources of stem cells for therapy, autologous and allogeneic stem cell transplantation, uses in cancer and other situations including the skin and nerves, diseases.
This supplement is intended to focus on stem cell biology. Stem cell properties, stem cell biology and therapeutic approaches are included within the supplement's scope.
Biomarker Insights aims to provide researchers working in this complex, quickly developing field with online, open access to highly relevant scholarly articles by leading international researchers. In a field where the literature is ever-expanding, researchers increasingly need access to upto-date, high quality scholarly articles on areas of specific contemporary interest. This supplement aims to address this by presenting high-quality articles that allow readers to distinguish the signal from the noise. The editor in chief hopes that through this effort, practitioners and researchers will be aided in finding answers to some of the most complex and pressing issues of our time.
T he concept of a stem cell was first proposed by the German biologist Ernst Haeckel to describe how multicellular organisms are derived from a unicellular organism , Takahashi and Yamanaka 6, 7 , and many others too numerous to list here, have significantly advanced the scientific and clinical applications of stem cells. As such, stem cells have transformed the manner in which scientists study human development and (hopefully) in the near future treat human disease. In this supplement, we present a series of articles that highlight the recent advances in the use of stem cells in disease modeling, drug discover, and regenerative medicine applications. These articles are organized into five subsections, which are previewed here.
Stem cells and the heart: Embracing opportunities and overcoming obstacles (Guest Editor: Dr. Stuart Campbell, Yale University). Cardiac research continues to be profoundly impacted by stem cell technology, especially with the development of methods that can transform cells from skin biopsies or blood samples into functioning cardiomyocytes. Such cells are finding use in regeneration and repair of the myocardium (reviewed by Jacot), basic research into cardiac developmental biology (reviewed by Rupert and Coulombe), and modeling of diseases in specific patients (reviewed by Schwan and Campbell). However, before these applications can reach their full potential, major obstacles must be overcome. Methods are needed that can increase the quantity and purity of cardiomyocytes produced from stem cells in order to make regenerative therapies realistic. , namely dialysis and kidney transplantation, highlight the urgent need for novel therapeutic strategies for patients with these conditions. In this special section on stem cellbased approaches for studying and treating kidney diseases, the most recent developments in stem cell and developmental biology and bioengineering are reviewed. In addition, the utility of in vivo and in vitro biomarkers in the identification, characterization, and derivation of stem cell and progenitor cell populations relevant to kidney development and regeneration are discussed. In the concise review entitled "Stem Cells/Progenitors in the Kidney", Valerius focuses on the multipotent progenitor cell populations in both the developing and adult kidneys that are crucial for the proper formation of nephrons, the individual functioning units of the kidney, as well as the repair of damaged nephrons after injury. This review highlights the methodologies used to identify these progenitor cells and their molecular regulation. Current approaches to reproducing and expanding these progenitors in vitro for regenerative applications are discussed in sub sequent reviews in this section.
Stem cell-based models of human disease (Guest Editor: Dr. Jean J. Kim, Baylor College of Medicine). A mini-review by Kim summarizes important advances in modeling cancer with induced pluripotent stem cells (iPSCs), with special emphasis on potential biomedical applications of iPSCs and their derivatives. In spite of significant interest in generating iPSCs from cancer cells to study the mechanisms of tumorigenesis and the positive role of oncogenes in enhancing the reprogramming process itself, reprogramming human primary cancer cells has proven to be paradoxically inefficient compared to non-cancerous tissues (coined the 'Reprogramming Paradox'), perhaps due to a combination of biological and technical limitations. Reports of successful reprogramming from various cancer cell lines and primary cancer cells are aptly summarized. Another review in this section by Brennand focuses on applications of iPSCs in the study of human neuropsychiatric disorders, where primary cell sources are limited and animal models often inadequate. With continued efforts in the field, human iPSCs are likely to offer new avenues to modeling human diseases, novel drug development, and cell-based therapies.
Biomaterials in stem-cell based therapies (Guest Editor:
Mehdi Nikkhah, Arizona State University). Stem cell-based therapies have attracted significant attention toward regeneration of various organs and tissues. The review article by Lee et al. provides a comprehensive overview on the use of synthetic biomaterials to regulate stem cell behavior for specific applications in regenerative medicine. The article primarily discusses the native microenvironment, termed the niche, and the role of biophysical and biochemical cues, which influence stem cell functions from migration to self-renewal and differentiation. The authors have presented the recent attempts in the synthesis of biomimetic materials, as delivery vehicles in cell-based therapies and neo-tissue formation. Specific properties of the previously developed synthetic matrices including immobilized growth factors, surface chemistry (ie, peptides and proteins) and topography (ie, pillar, grooves and ridges) have been outlined in detail as the key parameters guiding stem cellsubstrate interactions. This article finally discusses the future directions toward the design of novel biomaterials to control stem cell microenvironment for potential translation into clinical practice.
Cell-based regenerative strategies for neural injury and disease (Guest Editor: Sarah Stabenfeldt, Arizona State University). In this section, a collection of articles nicely frames the recent advances in and cutting-edge approaches for regeneration of neural injury and/or disease. Specifically, Seidlits et al. presents a thorough review on gene delivery developments over the past decade specifically for spinal cord injury. This elegant review not only highlights improvements in delivery strategies, but also potential gene targets aimed at mitigating immunological issues while promoting neural regeneration. Complementary to the Seidlits review, Stabenfeldt et al. delve into approaches to harness endogenous repair/regeneration response after brain injury. This review highlights injury-related chemokines and their impact on resident neural stem cells and summarizes how these known biological factors may be exploited for stem cell-and drug delivery-based therapies. Finally, Willerth and colleagues present a method to achieve robust dopaminergic neuron differentiation from human induced pluripotent stem cells using xenogenic-free culture conditions. Collectively this series of articles provides unique perspective into the historical and most recent advances in cellbased regenerative strategies for neural injury and/or disease.
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